Please ensure Javascript is enabled for purposes of website accessibility

Here's Why a COVID-19 Bill Sent HCA Shares Soaring 22.6% Today

By Todd Campbell - Updated Mar 19, 2020 at 3:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Washington is increasing funding for coronavirus medical care.

What happened

After President Trump signed legislation boosting Medicaid funding, shares of HCA Healthcare (HCA -1.42%) rallied 22.6% on Thursday.

So what

HCA Healthcare is one of the country's biggest healthcare companies, treating patients through 184 hospitals and 123 freestanding surgery centers in 21 states. The company reported revenue of $13.5 billion in Q4 2019. 

Hospital workers stand near an entrance to a hospital.

Image source: Getty Images.

Hospital operators are expected to see significant increases in demand because of admissions resulting from COVID-19, which can cause life-threatening respiratory complications.

As of Thursday afternoon, there were 236,420 confirmed cases worldwide, including 11,274 in the United States. A report from the Centers for Disease Control and Prevention (CDC) issued on Wednesday indicated that over 20% of 2,449 cases identified between Feb. 12 through March 16 required hospitalization.

As part of a broader financial relief package designed to address challenges arising from the spread of COVID-19 in the U.S., President Trump signed a bill into law on Wednesday that provides clarity into reimbursement for healthcare required by COVID-19 patients. The bill boosts the federal government's Medicaid matching funds by 6.2%. It also requires private health plans, Medicare, Medicaid, Medicare Advantage, and other public insurance plans to cover COVID-19 testing and visits to hospitals or physicians' offices at no cost to patients. It also makes $1 billion available to reimburse providers for testing uninsured individuals. 

Now what

Clarity into costs is important because there's significant uncertainty regarding the strain COVID-19 may put on hospital systems. In addition to potentially incurring significant unreimbursed expenses, hospital revenue is taking a hit because of delays to elective procedures, which contribute significantly to profitability. If COVID-19 cases continue climbing, Wednesday's legislation may be only the first step toward ensuring HCA Healthcare and its competitors remain financially viable throughout this crisis.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HCA Healthcare, Inc. Stock Quote
HCA Healthcare, Inc.
$172.58 (-1.42%) $-2.48

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.